PB Mental Health Guidelines from NICE
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2006) 30: 286-288. doi: 10.1192/pb.30.8.286
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in PB
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarrant, C. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tarrant, C. J.
Psychiatric Bulletin (2006) 30: 286-288
© 2006 The Royal College of Psychiatrists

Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care

Catharine Jane Tarrant, Consultant Psychiatrist

Sutton Health Centre, New Street, Sutton in Ashfield, Nottinghamshire NG17 1BW, e-mail: jane.tarrant{at}nottshc.nhs.uk

Declaration of interest

None.

AIMS AND METHOD

The routine monitoring of blood glucose indices for all patients on atypical antipsychotics in 2004 in a rural adult psychiatric sector was examined. Pragmatic and practical standards were based on consensus expert opinion, National Institute for Clinical Excellence and prescribing guidelines.

RESULTS

The audit was completed on 60 atypical antipsychotic prescriptions. Testing of blood glucose prior to the initiation or change of an atypical antipsychotic was largely followed, with an overall adherence rate of 82%. However, there were large differences in testing between in-patient and community settings. Routine yearly monitoring in the community was inadequate, with an adherence rate of 63%.

CLINICAL IMPLICATIONS

There is a welcome emphasis on the physical health of those with severe and enduring mental illness. New initiatives, including prescribing guidelines, the care programme approach and primary care registers, offer the opportunity to develop consistency and coordination between primary and secondary care in the routine monitoring of psychiatric treatments and physical health in these patients.


Related articles in PB:

Blood glucose monitoring in a regional secure unit
Muthusamy Natarajan and Karen D’Silva
PB 2007 31: 234. [Full Text]  



This article has been cited by other articles:


Home page
Schizophr BullHome page
T. R. E. Barnes, C. Paton, M.-R. Cavanagh, E. Hancock, D. M. Taylor, and on behalf of the UK Prescribing Observatory for Me
A UK Audit of Screening for the Metabolic Side Effects of Antipsychotics in Community Patients
Schizophr Bull, November 1, 2007; 33(6): 1397 - 1403.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

The knowledge-practice gap in metabolic monitoring of antipsychotic usage
Lena K Palaniyappan, et al.
PB Online, 31 Aug 2006 [Full text]
Monitoring of adults prescribed atypical antipsychotics
Kunal Kala
PB Online, 31 Aug 2006 [Full text]
Untitled
Sridhar Shanmugham
PB Online, 26 Feb 2007 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2006 The Royal College of Psychiatrists.